Skip to content
Review Open access

Integrated Computational Approaches for Natural Product-Based Drug Discovery: Target Prediction, Network Pharmacology, Molecular Docking, and ADMET Prediction

Sep 2026 · East Asian Journal of Multidisciplinary Research · 0 citations · 23 references

TL;DR

An integrated overview of target prediction, network pharmacology, molecular docking, and ADMET prediction within a unified computational workflow for natural product-based drug discovery is provided to support more efficient, systematic, and evidence-based natural product-driven drug discovery.

Abstract

Natural products remain an important source of drug discovery, while advances in computational approaches have accelerated early-stage candidate identification. This review aims to provide an integrated overview of target prediction, network pharmacology, molecular docking, and ADMET prediction within a unified computational workflow for natural product-based drug discovery. A narrative literature review was conducted by analyzing peer-reviewed articles published between 2015 and 2025 from major scientific databases. The reviewed studies consistently demonstrate that integrating complementary in silico approaches improves target identification, mechanism elucidation, lead compound prioritization, and pharmacokinetic assessment before experimental validation. This integrated workflow provides a practical framework to support more efficient, systematic, and evidence-based natural product-driven drug discovery.

Read PDF

Similar papers

Open access Aug 2026

ARTIFICIAL INTELLIGENCE-ASSISTED DRUG DESIGN COMBINED WITH MOLECULAR DOCKING FOR PRIORITIZATION OF POTENTIAL LEAD MOLECULES ACROSS FIVE THERAPEUTIC TARGETS

The integrated workflow supports computational narrowing of chemical space and target-specific lead prioritization and should be considered computational leads requiring biochemical, cellular, pharmacokinetic and toxicity validation before any therapeutic claim is made.

Harshveer Singh Jaitawat, C. S. Sharma, H. Udawat et al. · 0 citations
Open access Sep 2026

Drug Design Studio (DDS) 2.0: A Unified Platform for Network Pharmacology Integrated with Docking and Virtual Screening Workflow for Covalent/Non-Covalent Binders

The network-pharmacology module of Drug Design Studio (DDS) 2.0 is presented, a unified, user-friendly platform that streamlines the entire workflow—disease target retrieval, compound–target prediction, shared-target identification, protein–protein interaction (PPI) network construction, hub-gene ranking and Gene Ontol...

Mahmoud E. S. Soliman · 0 citations
Aug 2026

Integrating Network Pharmacology and Molecular Docking to Discover Novel Therapeutic Phytochemicals

The computational framework albeit with limitations in data quality and standardization, however, provides a solid framework for evidence-based natural product research, identifying new therapeutic phytochemicals and advancing the science of precision phytomedicine.

A. Shete · 1 citation
Review 2026

How Can Structure-Based Computational Methods Support Antibiotic Drug Discovery in Addressing Antimicrobial Resistance?

It is concluded that computational protein structure prediction plays a critical role in accelerating antibiotic drug discovery and offers substantial potential for addressing antimicrobial resistance through more efficient and data-driven therapeutic development strategies.

Hanshal Inagala · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.